Albumin can also be functionalized using targeting ligands to specifically address the overexpressed receptors on the surface of cancer cells, i.e., EGFR [45], folate receptors (FR) [46] or interleukin-13 alpha 2 receptor (IL13Rα2) [47]. The gene discussed is ALB; the disease is cancer.